Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Other 1Gynecologic 1

Conditions

Motor Activity 4Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Obesity 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Skin Neoplasms 1Sarcopenia 1Renal Insufficiency, Chronic 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Overweight 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Multiple Myeloma 1Melanoma 1Lymphoma 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Inflammation 1Hematopoietic and Lymphatic System Neoplasm 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 36Bevacizumab 25Cyclophosphamide 23Blood Specimen Collection 19Nivolumab 17Standard of Care 15Carboplatin 15Paclitaxel 14atezolizumab 13Gemcitabine 13Exercise 13Pemetrexed 11Fluorouracil 11Doxorubicin 11Cisplatin 11Cetuximab 10Radiotherapy 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Docetaxel 9130-nm albumin-bound paclitaxel 9durvalumab 8abemaciclib 8Temozolomide 8Surveys and Questionnaires 8Rituximab 8Prednisone 8Biopsy 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Resistance Training × 90 days × Clear all
NCT07159815 2026-06-01

REACT

Inland Norway University of Applied Sciences

Phase NA Active not recruiting
160 enrolled
Tumor-Agnostic

Neoplasms

NCT07606313 2026-05-26

ACES

OHSU Knight Cancer Institute

Phase NA Not yet recruiting
150 enrolled

Motor Activity, Neoplasms

NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡